Case Studies · Medical Devices & Surgery
A client assessing the market for contactless patient monitors in India's Tier 1 and Tier 2 cities needed adoption drivers from the people who live with the devices: what drives needs among current users and non-users, the strengths and weaknesses of adopted technology, and the uptake potential of the new approach. We conducted 70 in-depth discussions of 30–45 minutes with general ward nurses, head nurses, anesthesiologists, and medical directors — and ran a time-motion study of nurses'...
Case Studies · Precision Medicine & Genomics
A client exploring sequencing methodologies and technologies — with a focus on automation and future trends — needed lab leadership, not lab adjacency: directors at molecular clinical diagnostic labs running NGS in-house or outsourcing it. We fielded 90 surveys of 35 minutes across the US, UK, France, Italy, Germany, Spain, Japan, Korea, China, Singapore, and Australia, covering in-house NGS runs and automation processes, an adaptive choice-based conjoint on NGS automation, and forecasts for...
Case Studies · Rare Diseases
A client needed the real-world treatment landscape for ATTR amyloidosis across the US and EU: how often treaters encounter it, the diagnostic tools relied on to confirm it, the symptoms that prompt it as a differential, the management challenges, and the factors driving treatment decisions. We fielded 50 quantitative surveys of 30 minutes with cardiologists and neurologists — the two specialties that actually see these patients — on our hybrid CATI/online methodology. Recruitment to final raw...
Case Studies · Infectious Diseases & Vaccines
A leading pharmaceutical manufacturer runs this study with us twice every year: a chart-based tracking program in which treating physicians each complete 8 to 10 de-identified patient record forms with complete treatment history. Each wave captures the regimens in use, comorbidities present, viral load at presentation and currently, and the reasons behind every regimen change — real treatment behavior, drawn from real charts, fully de-identified by the treating physician before it ever...
Case Studies · Pharma Industry & Market Access
A pharmaceutical solutions provider needed the payment landscape, likely pricing under CMED evaluation, and reimbursement barriers for treatment options across Parkinson's disease, ADHD, schizophrenia, and knee osteoarthritis in Brazil. We ran in-depth interviews of 60 minutes with Brazilian payers — the people inside the reimbursement decision — covering unmet needs from the payer perspective, expectations of new entrants, likely price positioning, and the pathway to private-insurance...
Case Studies · Diagnostics & Laboratory
To improve its products and services, a client needed the point-of-care HbA1c testing market mapped: test volumes and trends, purchase pricing, the organization types performing tests and how they're funded, prevalent brands and their shares, and the healthcare-policy outlook. We conducted 50 in-depth discussions of 50 minutes each across EU5, China, Japan, Korea, and India — with HCPs, payers, and manufacturers in the same study. That's the network advantage: prescriber, funder, and...
Case Studies · Oncology
A client wanted to know whether the adverse-event guide shipped with its product genuinely helped the metastatic breast cancer care team manage side effects — not in theory, in the clinic. Through Growth+Connect we ran one-on-one qualitative interviews of around 45 minutes with eight US care-team experts: oncology nurses, nurse practitioners, nurse navigators, physician assistants, and patient care staff — the people who actually handle side-effect management in HR+/HER2- metastatic breast...
Case Studies · Oncology
One of the largest pharmaceutical manufacturers needed to understand treatment of platinum-resistant ovarian cancer patients — stage and line breakdowns, how treatment choice is actually determined, the challenges and prognosis, and how response is monitored. Through Growth+Connect, our expert engagement service, we connected the client with 24 US oncologists and gynecologic oncologists for one-hour, one-on-one discussions — including division leadership at major academic cancer centers and...
Case Studies · Infectious Diseases & Vaccines
A pharma company weighing entry into China's pneumococcal vaccine market needed the current and future landscape — and the competitive picture — before committing. Using our hybrid CATI/online methodology backed by desk research, we delivered the full engagement in 2.5 weeks, from recruitment through follow-up questions. The speed came from in-market, in-language recruiters working relationships we already held — not from cutting corners on verification. Market-entry decisions rarely wait....
Case Studies · Oncology
A pharmaceutical client preparing its next move in non-small cell lung cancer needed more than a literature view. It needed practicing oncologists to walk through what actually happens when a patient progresses on a third-generation EGFR TKI — and to react to a product profile against the treatment options they use today. We fielded a hybrid screenshare quantitative study: 25 surveys of 60 minutes each with oncologists across the UK, Germany, Spain, Italy, and France. The screenshare format...
Insights · Healthcare Market Research
For ten years, GRG Health has believed that the most valuable healthcare insights don’t come from dashboards alone—but from thoughtful, well-facilitated conversations. As 2025 comes to a close, this reflection looks back on a decade of trust, depth, and human dialogue, and forward to a future where technology supports insight without replacing the nuance that only real conversations can provide.
Insights · Oncology
Advanced prostate cancer treatment is shifting from traditional injections to innovative oral hormonal therapies, offering faster testosterone suppression and improved quality of life. This blog explores how personalization and patient-centricity are redefining care, marking a pivotal moment in prostate cancer management.
Insights · Neurology & Mental Health
Discover how Cryoneurolysis is transforming pain management, offering targeted, drug-free, non-surgical relief for chronic and post-operative pain, with minimal downtime and lasting results.
Insights · Pharma Industry & Market Access
The U.S. generic injectables market is expanding fast but so are drug shortages. Based on insights from 300 pharmacy directors, this blog unpacks the real issues behind the supply strain and what healthcare leaders say needs to change.
Insights · Medical Devices & Surgery
In a world where proactive health management is becoming increasingly vital, continuous health monitoring devices—especially smartwatches...
Insights · Precision Medicine & Genomics
The healthcare sector is increasingly adopting artificial intelligence (AI) and machine learning (ML) to streamline processes, improve...
Insights · Digital Health & AI
In the evolving landscape of medical diagnostics, the convergence of artificial intelligence (AI) and retinal imaging is opening new...
Insights · Diabetes, Obesity & Metabolic
Obesity is no longer seen merely as a lifestyle issue—it is a chronic disease that demands medical intervention. Affecting over 650...
Insights · Oncology
Small cell lung cancer (SCLC) accounts for roughly 13–15% of all lung cancer cases and is recognized for its rapid proliferation, early...
Insights · Women's & Pediatric Health
Asia's infant formula market is undergoing significant transformation, driven by demographic shifts, evolving consumer preferences, and...
Insights · Diabetes, Obesity & Metabolic
The global fight against obesity is entering a revolutionary phase. With the advent of GLP-1 (glucagon-like peptide-1) receptor agonists...
Insights · Pharma Industry & Market Access
Amyloidosis, a rare and often fatal disease characterized by the accumulation of misfolded proteins in organs and tissues, has long posed...
Insights · Respiratory & Sleep
Idiopathic Pulmonary Fibrosis (IPF) represents one of the most challenging and devastating interstitial lung diseases (ILDs), marked by...
Insights · Immunology & Autoimmune
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, yet serious neurological disorder rooted in the complex interactions...
